Sfmg, LLC Intra Cellular Therapies, Inc. Transaction History
Sfmg, LLC
- $1.24 Billion
- Q1 2025
A detailed history of Sfmg, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sfmg, LLC holds 1,748 shares of ITCI stock, worth $230,508. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,748Holding current value
$230,508% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
414Shares Held
83.6MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.52MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$424 Million0.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$402 Million3.71% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...